Mangrove Partners Johnson & Johnson Transaction History
Mangrove Partners
- $778 Million
- Q3 2025
A detailed history of Mangrove Partners transactions in Johnson & Johnson stock. As of the latest transaction made, Mangrove Partners holds 4,712 shares of JNJ stock, worth $940,420. This represents 0.11% of its overall portfolio holdings.
Number of Shares
4,712Holding current value
$940,420% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding JNJ
# of Institutions
4,816Shares Held
1.73BCall Options Held
20.4MPut Options Held
17.2M-
Vanguard Group Inc Valley Forge, PA237MShares$47.2 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY198MShares$39.6 Billion0.67% of portfolio
-
State Street Corp Boston, MA132MShares$26.4 Billion0.88% of portfolio
-
Jpmorgan Chase & CO New York, NY58.6MShares$11.7 Billion0.72% of portfolio
-
Geode Capital Management, LLC Boston, MA56.2MShares$11.2 Billion0.69% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $522B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...